The Centers for Medicare & Medicaid Services this week awarded 14 states and the District of Columbia planning grants totaling $48.5 million to increase access to evidence-based treatment and recovery services for Medicaid patients with substance use disorders. Alabama, Connecticut, Delaware, the District of Columbia, Illinois, Indiana, Kentucky, Maine, Michigan, Nevada, New Mexico, Rhode Island, Virginia, Washington and West Virginia will use the grants to assess state needs, recruit and train providers, and improve reimbursement to expand treatment capacity. Section 1003 of the Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 authorized the planning grants for a demonstration project to increase Medicaid provider capacity to treat SUDs. CMS will select up to five of the states to receive an enhanced federal matching rate for SUD services for three years under the project.

Headline
The cigarette smoking rate among U.S. adults dropped to 9.9% in 2024, the lowest level ever recorded, according to a report by the New England Journal of…
Headline
A study published by BMJ found that glucagon-like peptide-1 (GLP-1) drugs could help reduce the risk of various substance use disorders, including for alcohol…
Headline
The Centers for Medicare & Medicaid Services March 11 issued guidance to state survey agency directors clarifying and reinforcing the roles and…
Headline
The Medicaid and CHIP Payment and Access Commission March 12 released its March 2026 report to Congress. The first chapter includes a recommendation to…
Headline
The Substance Abuse and Mental Health Services Administration announced March 6 that it will award $69.1 million in grants for mental health and suicide…
Headline
The Centers for Medicare & Medicaid Services March 6 issued guidance to states on transitioning to six-month Medicaid redeterminations in 2027, a change…